Skip to content

Efficacy and safety of topical isoflavone products on skin in postmenopausal women

Efficacy and safety of topical isoflavone products on skin in postmenopausal women

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210807004
Enrollment
100
Registered
2021-08-07
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal women isoflavone genistein serum topical postmenopausal

Interventions

Topical isoflavone serum,Topical serum base
Active Comparator Dietary Supplement,Placebo Comparator Dietary Supplement
Sample,Placebo

Sponsors

Science and Technology Park, Chiang Mai University (STeP)
Lead Sponsor
Faculty of Medicine, Chiang Mai University
Collaborator

Eligibility

Sex/Gender
Female
Age
48 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women (48-65 years) who have no menstruation for at least 12 months 2. FSH >30 mU/mL 3. BMI = 18-30 kg/m2 4. Normal CBC, electrolytes, Liver and Renal function tests

Exclusion criteria

Exclusion criteria: 1. Person who is currently taking oestrogen hormone or isoflavone supplementation within 6 months of recruitment. 2. Person who is allergy to soy component. 3. Person who has a medical history of skin cancers or skin infection or any chronic diseases that contraindicated to soy products. 4. Person who uses other dietary supplement, herbals, vitamins and minerals, or any substance that affected their skin such as antibiotics, corticosteroids, or immunosuppressant agents within 3 month of recruitment. 4. Person who is alcohol drinking, smoking or recreational drug use.

Design outcomes

Primary

MeasureTime frame
Quality of Skin 0, 3 and 6 weeks Visiometer, Visiopore, Corneometer and Mexameter

Secondary

MeasureTime frame
Patient satisfaction week 3 and 6 satisfactory survey

Countries

Thailand

Contacts

Public ContactMingkwan Na Takuathung

Department of Pharmacology, Faculty of Medicine, Chiang Mai University

mingkwan.n@cmu.ac.th0815384927

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026